ARISTOTLE trial finds new drug may revolutionize the treatment of atrial fibrillation
Wednesday, October 26, 2011 - 01:30
in Health & Medicine
New research has the potential to revolutionize the treatment of atrial fibrillation (AF), a condition affecting a quarter of a million Canadians which is expected to strike even more in the coming years, as the Canadian population ages.